EQL Pharma AB (OSTO:EQL) Total Stockholders Equity: kr250.3 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

OSTO:EQL EQL Pharma AB OSTO:EQL
40 GF Score
Price kr25.60
! 6 Warning Signs
View Full Analysis

What is EQL Pharma AB Total Stockholders Equity?

EQL Pharma AB OSTO:EQL -2.66% 40 Total Stockholders Equity is kr250.3 Mil as of Jun. 2026. GuruFocus rates OSTO:EQL with a GF Score™ of 40/100. The stock has 6 warning signs investors should review.

EQL Pharma AB's Total Stockholders Equity for the quarter that ended in Jun. 2026 was kr250.3 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. EQL Pharma AB's Book Value per Share for the quarter that ended in Jun. 2026 was kr8.48. The ratio of a company's debt over equity can be used to measure how leveraged this company is. EQL Pharma AB's Debt-to-Equity for the quarter that ended in Jun. 2026 was 1.94.

EQL Pharma AB  (OSTO:EQL) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

EQL Pharma AB's Book Value per Share for the quarter that ended in Jun. 2026 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(250.305-0)/29.530
=8.48

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

EQL Pharma AB's Debt-to-Equity for the quarter that ended in Jun. 2026 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(138.749 + 345.616) / 250.305
=1.94

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

EQL Pharma AB Total Stockholders Equity Related Terms

EQL Pharma AB Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for EQL Pharma AB's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

EQL Pharma AB Total Stockholders Equity Chart

EQL Pharma AB Annual Data
Trend Dec16 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Total Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 123.63 154.75 177.73 221.03 267.06

EQL Pharma AB Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 230.87 260.00 269.78 267.06 250.31
OSTO:EQL
40GF Score
EQL Pharma AB OSTO:EQL
Total Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Total Stockholders Equity of kr250.3 Mil mean?
EQL Pharma AB (OSTO:EQL) has a Total Stockholders Equity of kr250.3 Mil as of Jun. 2026. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for EQL Pharma AB and its competitors.
Is EQL Pharma AB's Total Stockholders Equity too high?
EQL Pharma AB's current Total Stockholders Equity is kr250.3 Mil. Overall, EQL Pharma AB has a GF Score™ of 40/100, reflecting its overall financial health beyond just this single metric.
How does EQL Pharma AB's Total Stockholders Equity compare to ZTS?
EQL Pharma AB's Total Stockholders Equity of kr250.3 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Drug Manufacturers company?
A good Total Stockholders Equity depends on the Drug Manufacturers industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for EQL Pharma AB and its competitors. EQL Pharma AB's current Total Stockholders Equity is kr250.3 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is EQL Pharma AB stock overvalued right now?
EQL Pharma AB (OSTO:EQL) has a current Total Stockholders Equity of kr250.3 Mil. The current Total Stockholders Equity is kr250.3 Mil. EQL Pharma AB's overall GF Score™ is 40/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For EQL Pharma AB (OSTO:EQL), the current Total Stockholders Equity is kr250.3 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

EQL Pharma AB Business Description

Other Exchanges 7JK:Germany
Address Stortorget 1, 3rd Floor, Lund, SWE, 222 23
EQL Pharma AB is a pharmaceutical company focused on efficiently and thoughtfully developing and marketing generic drugs. The company operates in one segment, which is medicine. Its niche generics are divided into four parts based on four sales and marketing models: Retail, Hospital, Branded, and Tests. EQL Pharma specializes in identifying, developing, and selling generics, i.e., medicines that are medically equivalent to originator medicines. The company operates in Sweden, Denmark, Norway, Finland, the rest of Europe, and outside Europe, generating the majority of its revenue from Sweden.
40GF Score

Get the complete analysis for OSTO:EQL

Total Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr25.60
Price